Pneumococcal vaccine should still be given to adults aged ≥65 years, but no longer to all adults in that population. Find out what you know - and what you may need to know.
The update amends the ACIP’s 2014 statement that recommended routine use of the pneumococcal conjugate vaccine (PCV13) in series with pneumococcal polysaccharide vaccine (PPSV23) for all adults in this age range. For a brief review of the full history, click here.
To find out what you know-and might need to know-about administration this year, try the 5 questions that follow.